Oral matrix formulations comprising licarbazepine

Details Oral matrix formulations comprising licarbazepine Oral matrix formulations comprising licarbazepine

A - Human Necessities

61

K

A61K 9/22 (2006.01) A61K 9/26 (2006.01) A61K 31/55 (2006.01)

Patent

CA 2558787

The invention relates to pharmaceutical compositions comprising 10,11-dihydro- 10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide (also referred to as "licarbazepine") as drug substance.

L'invention concerne des compositions pharmaceutiques contenant 10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azépine-5-carboxamide (désigné également "licarbazépine") en tant que substance médicamenteuse active.

Affiliated with

Also associated with

Rating

Oral matrix formulations comprising licarbazepine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oral matrix formulations comprising licarbazepine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral matrix formulations comprising licarbazepine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1934895